Navigation Links
IMPAKT Breast Cancer Conference press program
Date:5/6/2010

Press releases (embargo: 6 May, 16:45 CEST)

J. Hicks, USA
Genome breakthrough allows scientists to identify and profile tumor cells from very small samples
Researchers have developed a powerful new technique for analyzing the genome of single tumor cells. The breakthrough allows them to study in fine detail the biology of how tumors develop.

S. Loi, BE
Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule.

B. Haine-Kains, USA
Simple gene test identifies clinically important sub-types of breast cancer
A simple genetic test that uses just three genes is among the most effective means of classifying breast cancer into sub-types.

A. Giordano, USA
Survival in metastatic breast cancer directly linked to circulating tumor cells
A new study of metastatic breast cancer shows that the number of circulating tumor cells patients have in their blood directly correlates with the length of their survival.

The full conference program is available at http://www.esmo.org/events/breast-2010-impakt/program.html

Press conference

Thursday, 06/05 at 12:00-13:00 (CEST)

Hosts:
Dr Martine Piccart, Head of Chemotherapy Unit, Jules Bordet Institute in Brussels, IMPAKT Co-Founder
Dr Angelo Di Leo, Head of Medical Oncology Unit, Department of Oncology, Hospital of Prato, Italy, IMPAKT2010 Co-Chair
Dr Christos Sotiriou, Head of Functional Genomics & Translational Research Unit, Jules Bordet Institute in Brussels, IMPAKT2010 Co-Chair

Topics:

  • The impact of methodology in biomarkers research and validation
  • Translational research impact on the next decade
  • Impact of neo-adjuvant trial results in the future treatment practice


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
2. Simple gene test identifies clinically important subtypes of breast cancer
3. Survival in metastatic breast cancer directly linked to circulating tumor cells
4. Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds
5. Broccoli May Help Battle Breast Cancer
6. Edgy, Sassy And Informative: New Website for Breast Cancer Survivors To Get Real About Their 'New Normal'
7. Whole body MRI is highly accurate in the early detection of breast cancer metastases
8. PMH cancer researchers link ovarian hormone to breast stem cells growth
9. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
10. Aggressive Action Urged When Evaluating Breast Lesions
11. Indeterminate breast lesions found in high-risk patients should be evaluated aggressively to exclude malignancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... MALO, FRANCE (PRWEB) , ... January 21, 2017 , ... ... of the Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER ... East Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to ...
(Date:1/21/2017)... ... 2017 , ... The Nobel Biocare™ dental implant company is ... its creos™ line of bone regenerative products. Specifically, the Nobel Biocare™ ... creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In addition ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Doctor C ... it attended the January ECRM trade show to continue the marketing and distribution of ... C supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. ...
(Date:1/20/2017)... ... , ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in ... has been life-saving as she has been on the trial for more than ... with ovarian cancer in 2009. She underwent standard chemotherapy but a year later went ...
(Date:1/20/2017)... ... , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on to ... published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, ... years of age, he joined the Navy and got married right out of boot camp. ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
(Date:1/20/2017)... Research and Markets has announced the addition of ... OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast ... ... Sales Volume, Company Analysis and Forecast to 2022 provides a ... The growing prevalence of hearing impairment coupled with an ...
(Date:1/20/2017)... -- Stock-Callers.com today evaluates the following Drug Manufacturers ... Nordisk A/S (NYSE: NVO ), Sucampo Pharmaceuticals Inc. ... (NASDAQ: PTX ). These stocks belong to the ... 2017, finishing near its session lows. As per a NASDAQ ... shares of health care companies in the S&P 500 also ...
Breaking Medicine Technology: